[Effect of human regulatory myelopeptides on the elaboration of a factor inhibiting leukocyte migration].
Some properties of the regulatory peptides from human bone marrow have been investigated. It has been determined that the activity of the regulatory peptides was different in healthy donors and patients with agammaglobulinemia and paraproteinemia.